Drug intelligence / Profile preview

glehnia littoralis extract

Development stage
Preclinical
Administration
Oral, Topical
01

Overview

Glehnia littoralis extract (GLE) is a **natural plant extract** derived from *Glehnia littoralis*, a medicinal halophyte plant from the Apiaceae family. The extract is obtained primarily from the **leaves** and **roots** of the plant, though different extraction methods and plant parts may be used. GLE contains multiple **phenolic compounds** including quercetin, chlorogenic acid, and riboflavin, as well as **coumarins** (including pyranocoumarins and furanocoumarins such as imperatorin, psoralen, and bergapten), **lignanoids**, **flavonoids**, **terpenoids**, **polyacetylenes** (including falcarinol and panaxydiol), and other bioactive compounds[1][3]. The extract demonstrates **antioxidant** and **anti-inflammatory** properties through multiple mechanisms, including inhibition of COX-2, iNOS, and modulation of NF-κB and MAPK signaling pathways[1][2]. It has shown **neuroprotective effects** by upregulating BDNF and CREB expression, reducing acetylcholinesterase (AChE) activity, and promoting Nrf2/HO-1 signaling[2]. Traditional uses include treatment of **chronic bronchitis**, **immune-related diseases**, **fevers**, and **inflammation**[1][3][5]. The extract has been investigated for potential applications in **memory disorders**, **neuroinflammation**, **skin inflammation**, and as an **immunomodulatory agent**[1][2][3].

Other names
GLEGlehnia littoralis Fr. Schmidt ex Miq extractstandardized extract of Glehnia littoralis
02

Targets

MAPK3 (Mitogen-activated protein kinase 1)NF-κBNOS2 (Nitric Oxide Synthase 2)

Beyond the preview

Go deeper on glehnia littoralis extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glehnia littoralis extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call